COMMUNIQUÉS West-GlobeNewswire

Ziopharm Oncology Reports on Status of Investigational New Drug Application for Phase 1 Trial to Evaluate CD19-targeted CAR T Therapy

18/06/2018 - 13:30

BOSTON, June 18, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP) today announced the U.S. Food and Drug Administration (FDA) placed on clinical hold a Phase 1 trial to evaluate CD19-specific CAR-T [...]

Myriad’s BRACAnalysis CDx® Supplementary PMA Accepted by FDA for Review as a Companion Diagnostic for Talazoparib in Metastatic Breast Cancer

18/06/2018 - 13:05

SALT LAKE CITY, June 18, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that the U.S. Food and Drug Administration (FDA) has [...]

Helius Medical Technologies, Inc. Provides Update on its Anticipated Submission for FDA Clearance of the PoNS™ Device

18/06/2018 - 13:01

NEWTOWN, Pa., June 18, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, updated today the expected [...]

ObsEva SA Achieves Primary and Secondary Endpoints for EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis

18/06/2018 - 13:00

Partial suppression of estradiol with moderate dose (75mg) of linzagolix demonstrated highly significant reduction of pain and improvement of patient well-being High dose (200mg) of linzagolix achieves full estradiol [...]

Rhythm Pharmaceuticals Announces New Topline Clinical Data from Ongoing Phase 2 Basket Studies Evaluating Setmelanotide in Rare Genetic Disorders of Obesity

18/06/2018 - 13:00

-- Further Improvements Observed in Bardet-Biedl Syndrome Patients; Initial Proof-of-Concept Data in Alström Syndrome Demonstrates Significant Weight Loss and Decreased Hunger -- -- Rhythm Plans to Initiate Combined [...]

Sunesis Pharmaceuticals Announces Presentations at the EHA Annual Meeting

18/06/2018 - 13:00

Université Claude Bernard de Lyon Study Provides Preclinical Validation of Vecabrutinib Activity Against Ibrutinib-Resistant BTK C481S Mutated Lymphomas ERIC Study Shows Half of Ibrutinib-Relapse CLL Patients Carry BTK [...]

The Dementia Discovery Fund and Immuneering announce a Research Collaboration to identify novel drug targets and drug candidates for Alzheimer's disease

18/06/2018 - 13:00

The Dementia Discovery Fund and Immuneering announce a Research Collaboration to identify novel drug targets and drug candidates for Alzheimer's disease Cambridge, MA and London, 18 June 2018 - The Dementia Discovery [...]

Stemline Therapeutics Announces Positive Clinical Data from ELZONRISTM (tagraxofusp; SL-401) Trials in BPDCN, CMML and MF Delivered at the EHA Congress

18/06/2018 - 13:00

NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today that positive clinical data from [...]

Lexicon Pharmaceuticals to Present New Clinical Data at 78th American Diabetes Association Scientific Sessions

18/06/2018 - 13:00

THE WOODLANDS, Texas, June 18, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX), today announced that new clinical data for sotagliflozin will be presented at the upcoming 78 th American Diabetes [...]

Agios Announces Initiation of Global Phase 3 Trial (ACTIVATE) of AG-348 in Adults with Pyruvate Kinase Deficiency Who Are Not Regularly Transfused

18/06/2018 - 13:00

- Broad Late-stage Development Plan in Place with Two Pivotal Trials and Patient Registry Open for Enrollment - CAMBRIDGE, Mass., June 18, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in [...]

Microbot Medical Inc. Announces European Patent Office's Intent to Grant Patent for Device for the Prevention of Shunt Stenosis

18/06/2018 - 13:00

HINGHAM, Mass., June 18, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today [...]

Solid Biosciences Announces FDA Removes Clinical Hold on SGT-001

18/06/2018 - 13:00

- Activities to Resume Enrollment in IGNITE DMD Phase I/II Clinical Trial are Underway - Conference Call Scheduled for Today at 8:30 A.M. ET CAMBRIDGE, Mass., June 18, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. ( [...]

Urgent need for blood donors by Canada Day

18/06/2018 - 13:00

More than 23,000 donors across Canada needed by July 2 OTTAWA, June 18, 2018 (GLOBE NEWSWIRE) -- Canadian Blood Services is urging Canadians to help meet patients’ needs this summer by donating blood and by encouraging [...]

Urgent besoin de donneurs de sang d’ici la fête du Canada

18/06/2018 - 13:00

Les centres de collecte du pays ont besoin de plus de 23 000 donneurs d’ici le 2 juillet OTTAWA, 18 juin 2018 (GLOBE NEWSWIRE) -- La Société canadienne du sang demande aux Canadiens de donner du sang et d’encourager les [...]

Auxly Announces Signing of Definitive Joint Venture Agreement With Peter Quiring to Build State-Of-The-Art 1.4 Million Square Foot Greenhouse

18/06/2018 - 13:00

VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX-V:XLY) (" Auxly " or the " Company ") is pleased to announce that further to its previously announced transaction on February [...]

BeyondSpring to Host First-Quarter 2018 Financial Results Conference Call on June 21, 2018

18/06/2018 - 13:00

NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc . (NASDAQ:BYSI), a global, clinical-stage biopharmaceutical company focused on the development of transformative cancer therapies, today announced that the [...]

Geron Reports Imetelstat Oral Presentation at European Hematology Association Congress

18/06/2018 - 12:45

Updated Clinical Data from Original Part 1 of IMerge in Myelodysplastic Syndromes (MDS) Presented MENLO PARK, Calif., June 18, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced the oral [...]

Quotient Limited Reports Concordance Data from the MosaiQ European Field Trial

18/06/2018 - 12:30

Field trial concordance data exceed targeted criteria Planned issuance of $36 million in Senior Secured Notes JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage [...]

Catalyst Biosciences Provides Update on CB 2679d/ISU304 Factor IX Clinical Program in Hemophilia B

18/06/2018 - 12:30

Conference call and webcast to be held today, June 18, 2018 at 8:30 a.m. EDT SOUTH SAN FRANCISCO, Calif., June 18, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (Nasdaq:CBIO), a clinical-stage biopharmaceutical [...]